SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
d -Cycloserine as an Augmentation Strategy With Cognitive-Behavioral Therapy for Social Anxiety Disorder
16 references·16 citing·47 second hopsampled
d -Cycloserine as an Augmentation Strategy With Cognitive-Behavioral Therapy for Social Anxiety Disorder (2013)d -Cycloserine as an Augmentation Strateg…Social Phobia (2015)Social PhobiaA Randomized Placebo-Controlled Trial of d-Cycloserine to Enhance Exposure Therapy for Posttraumatic Stress Disorder (2012)A Randomized Placebo-Controll…Efficacy of D-Cycloserine for Enhancing Response to Cognitive-Behavior Therapy for Panic Disorder (2009)Efficacy of D-Cycloserine for…Augmentation of Behavior Therapy With d -Cycloserine for Obsessive-Compulsive Disorder (2008)Augmentation of Behavior Ther…A Randomized Controlled Trial of D-Cycloserine Enhancement of Exposure Therapy for Social Anxiety Disorder (2008)A Randomized Controlled Trial…D-Cycloserine Augmented Exposure Therapy for Obsessive-Compulsive Disorder (2007)D-Cycloserine Augmented Expos…Cognitive Factors that Maintain Social Anxiety Disorder: a Comprehensive Model and its Treatment Implications (2007)Cognitive Factors that Mainta…Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder (2006)Augmentation of Exposure Ther…Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication (2005)Lifetime Prevalence and Age-o…Fluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placeboin Generalized Social Phobia (2004)Fluoxetine, Comprehensive Cog…Cognitive Enhancers as Adjuncts to Psychotherapy (2004)Cognitive Enhancers as Adjunc…Cognitive Therapy Versus Fluoxetine in Generalized Social Phobia: A Randomized Placebo-Controlled Trial. (2003)Cognitive Therapy Versus Fluo…Paroxetine Treatment of Generalized Social Phobia (Social Anxiety Disorder) (1998)Paroxetine Treatment of Gener…Cognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia (1998)Cognitive Behavioral Group Th…Phenelzine vs Atenolol in Social Phobia (1992)Phenelzine vs Atenolol in Soc…A New Depression Scale Designed to be Sensitive to Change (1979)A New Depression Scale Design…Fear Processing, Psychophysiology, and PTSD (2018)Fear Processing, Psychophysio…Core Mechanisms of Cognitive Behavioral Therapy for Anxiety and Depression (2017)Core Mechanisms of Cognitive …RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER (2016)RANDOMIZED TRIAL OF D-CYCLOSE…Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d -Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder (2016)Efficacy of Augmentation of C…Baseline psychophysiological and cortisol reactivity as a predictor of PTSD treatment outcome in virtual reality exposure therapy (2016)Baseline psychophysiological …Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions (2015)Enhancement of Psychosocial T…d -Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants (2015)d -Cycloserine vs Placebo as …Clinical Features, Cognitive Biases, and Treatment of Body Dysmorphic Disorder (2015)Clinical Features, Cognitive …Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders (2015)Augmentation of cognitive and…Predicting rapid response to cognitive-behavioural treatment for panic disorder: The role of hippocampus, insula, and dorsolateral prefrontal cortex (2014)Predicting rapid response to …d-Cycloserine Augmentation of Cognitive Behavioral Therapy for Anxiety Disorders: an Update (2014)d-Cycloserine Augmentation of…d -CYCLOSERINE FOR TREATING ANXIETY DISORDERS: MAKING GOOD EXPOSURES BETTER AND BAD EXPOSURES WORSE (2014)d -CYCLOSERINE FOR TREATING A…Conditioned Fear Associated Phenotypes as Robust, Translational Indices of Trauma-, Stressor-, and Anxiety-Related Behaviors (2014)Conditioned Fear Associated P…Yohimbine Enhancement of Exposure Therapy for Social Anxiety Disorder: A Randomized Controlled Trial (2013)Yohimbine Enhancement of Expo…SLEEP QUALITY PREDICTS TREATMENT OUTCOME IN CBT FOR SOCIAL ANXIETY DISORDER (2013)SLEEP QUALITY PREDICTS TREATM…d-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions (2013)d-cycloserine enhancement of …Generalized expectancies for internal versus external control of reinforcement. (1966)Self-efficacy: Toward a unifying theory of behavioral change. (1977)The need to belong: Desire for interpersonal attachments as a fundamental human motivation. (1995)Acceptance and mindfulness-based therapy: New wave or old hat? (2007)Fear of the unknown: One fear to rule them all? (2016)Social media use, social anxiety, and loneliness: A systematic review (2021)Child abuse: Adolescent records vs. adult recall (1990)Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States (1994)The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) (2004)Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication (2005)The Prevalence and Correlates of Eating Disorders in the National Comorbidity Survey Replication (2006)A RATING SCALE FOR DEPRESSION (1960)Development of a Rating Scale for Primary Depressive Illness (1967)Diagnostic Criteria for Use in Psychiatric Research (1972)The PHQ-9 (2001)The PHQ-9: A New Depression Diagnostic and Severity Measure (2002)The validity of the Hospital Anxiety and Depression Scale (2002)ECDEU Assessment Manual for Psychopharmacology (1976)Structured Clinical Interview for DSM-IV Axis I Disorders (1997)Fear Extinction in Traumatized Civilians with Posttraumatic Stress Disorder: Relation to Symptom Severity (2010)How the Neurocircuitry and Genetics of Fear Inhibition May Inform Our Understanding of PTSD (2010)Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options (2020)Statistical Methods for Meta-Analysis (1988)The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001)Size and burden of social phobia in Europe (2005)Psychological treatment of social anxiety disorder: a meta-analysis (2008)A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder (2009)Measurement of social-evaluative anxiety. (1969)The Structured Clinical Interview for DSM-III-R (SCID) (1992)How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta‐analytic update of the evidence (2016)An Inventory for Measuring Depression (1961)Manual for the state-trait anxiety inventory (form Y) : "self-evaluation questionnaire" (1970)Response Variation following Trauma: A Translational Neuroscience Approach to Understanding PTSD (2007)Understanding how and why psychotherapy leads to change (2008)Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (2014)An inventory for measuring clinical anxiety: Psychometric properties. (1988)Enduring Effects for Cognitive Behavior Therapy in the Treatment of Depression and Anxiety (2005)Attention training for generalized social anxiety disorder. (2009)Cognitive Therapy for Depression (2012)Diagnostic and Statistical Manual of Mental Disorders (2013)Research Diagnostic Criteria (1978)Brief standard self-rating for phobic patients (1979)Cognitive-behavioral and pharmacological treatment for social phobia: A meta-analysis. (1997)Treatment of Social Phobia With Gabapentin (1999)Screening for social anxiety disorder with the self-report version of the Liebowitz Social Anxiety Scale (2008)World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision (2008)Treatment of anxiety disorders (2017)
this work references cited by second hop· second hop is a sample of the most-cited connections

References

  • 2005Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication20,388 cited
  • 1979A New Depression Scale Designed to be Sensitive to Change13,964 cited
  • 2015Social Phobia2,264 cited
  • 2007Cognitive Factors that Maintain Social Anxiety Disorder: a Comprehensive Model and its Treatment Implications1,064 cited
  • 2004Cognitive Enhancers as Adjuncts to Psychotherapy1,063 cited
  • 1998Cognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia584 cited
  • 2006Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder560 cited
  • 2003Cognitive Therapy Versus Fluoxetine in Generalized Social Phobia: A Randomized Placebo-Controlled Trial.558 cited
  • 1992Phenelzine vs Atenolol in Social Phobia444 cited
  • 2004Fluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placeboin Generalized Social Phobia415 cited
  • 2007D-Cycloserine Augmented Exposure Therapy for Obsessive-Compulsive Disorder384 cited
  • 2008Augmentation of Behavior Therapy With d -Cycloserine for Obsessive-Compulsive Disorder358 cited
  • 1998Paroxetine Treatment of Generalized Social Phobia (Social Anxiety Disorder)348 cited
  • 2008A Randomized Controlled Trial of D-Cycloserine Enhancement of Exposure Therapy for Social Anxiety Disorder

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

326 cited
  • 2009Efficacy of D-Cycloserine for Enhancing Response to Cognitive-Behavior Therapy for Panic Disorder251 cited
  • 2012A Randomized Placebo-Controlled Trial of d-Cycloserine to Enhance Exposure Therapy for Posttraumatic Stress Disorder220 cited
  • Cited by

    • 2015Clinical Features, Cognitive Biases, and Treatment of Body Dysmorphic Disorder123 cited
    • 2013d-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions114 cited
    • 2015d -Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants109 cited
    • 2014d -CYCLOSERINE FOR TREATING ANXIETY DISORDERS: MAKING GOOD EXPOSURES BETTER AND BAD EXPOSURES WORSE108 cited
    • 2016Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d -Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder107 cited
    • 2014Conditioned Fear Associated Phenotypes as Robust, Translational Indices of Trauma-, Stressor-, and Anxiety-Related Behaviors105 cited
    • 2016Baseline psychophysiological and cortisol reactivity as a predictor of PTSD treatment outcome in virtual reality exposure therapy96 cited
    • 2015Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders92 cited
    • 2013Yohimbine Enhancement of Exposure Therapy for Social Anxiety Disorder: A Randomized Controlled Trial86 cited
    • 2018Fear Processing, Psychophysiology, and PTSD86 cited
    • 2014d-Cycloserine Augmentation of Cognitive Behavioral Therapy for Anxiety Disorders: an Update76 cited
    • 2017Core Mechanisms of Cognitive Behavioral Therapy for Anxiety and Depression75 cited
    • 2014Predicting rapid response to cognitive-behavioural treatment for panic disorder: The role of hippocampus, insula, and dorsolateral prefrontal cortex74 cited
    • 2015Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions70 cited
    • 2016RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER69 cited
    • 2013SLEEP QUALITY PREDICTS TREATMENT OUTCOME IN CBT FOR SOCIAL ANXIETY DISORDER68 cited